Urology · Cincinnati, OH
NPI
1104142389
Since 2010
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4360 Ferguson Dr Ste 100
Cincinnati, OH, 45245
Phone (513) 841-7750
Groups this clinician bills Medicare through
Medicare paid, 2024
$251K
8,055 services
Medicare patients, 2024
562
Average age 74
Drug cost, 2024
$2.0M
3,185 prescriptions
Company payments, 2025
$1,892
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian J Minnillo was code J0897 (injection, denosumab, 1 mg), 1,260 times for 15 patients. In total Brian J Minnillo billed 8,055 services in 105 codes, and Medicare paid $251K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,260 | 15 | $20.16 | $25K |
| 81002 Clinical Chemistry | Office | 485 | 370 | $3.37 | $1,635 |
| 99214 Office E&M - Established | Office | 476 | 350 | $89.27 | $42K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 383 | 304 | $11.68 | $4,475 |
| 51798 Ultrasound - Nonspecific | Office | 242 | 193 | $7.45 | $1,802 |
| 36415 Venipuncture Blood Collection | Office | 217 | 128 | $8.65 | $1,877 |
| 84153 Clinical Chemistry | Office | 187 | 121 | $18.02 | $3,370 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 154 | 39 | $50.13 | $7,719 |
| 99204 Office E&M - New | Office | 113 | 113 | $113.20 | $13K |
| 86316 Immunoassay | Office | 79 | 59 | $20.39 | $1,611 |
| 84154 Clinical Chemistry | Office | 79 | 59 | $18.02 | $1,424 |
| 84403 Clinical Chemistry | Office | 60 | 36 | $25.29 | $1,517 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 59 | 30 | $38.99 | $2,300 |
| 52000 Cystourethroscopy | Facility | 49 | 47 | $56.27 | $2,757 |
| 87086 Bacterial Culture | Office | 44 | 38 | $7.91 | $348 |
By year: 2022 $208K for 7,968 services; 2023 $335K for 8,692 services; 2024 $251K for 8,055 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 485 | 370 | $3.37 | $1,635 |
| 36415 Venipuncture Blood Collection | 217 | 128 | $8.65 | $1,877 |
| 84153 Clinical Chemistry | 187 | 121 | $18.02 | $3,370 |
| 86316 Immunoassay | 79 | 59 | $20.39 | $1,611 |
| 84154 Clinical Chemistry | 79 | 59 | $18.02 | $1,424 |
| 84403 Clinical Chemistry | 60 | 36 | $25.29 | $1,517 |
| 87086 Bacterial Culture | 44 | 38 | $7.91 | $348 |
| 80053 Clinical Chemistry | 39 | 24 | $10.35 | $404 |
| 85027 Blood Count | 29 | 24 | $6.34 | $184 |
| 87088 Bacterial Culture | 25 | 22 | $7.93 | $198 |
Medicare prescription drug claims, 2024
In 2024, the drug Brian J Minnillo prescribed most often to Medicare patients was Tamsulosin Hcl, with 684 prescriptions and refills. In total Brian J Minnillo wrote 3,185 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 684 | 1,586 | 212 | $7,225 |
| Finasteride Generic | 661 | 1,530 | 191 | $6,781 |
| Levofloxacin Generic | 191 | 191 | 159 | $592 |
| Abiraterone Acetate Generic | 178 | 202 | 23 | $485K |
| Prednisone Generic | 148 | 214 | 22 | $572 |
| Trospium Chloride Generic | 137 | 211 | 39 | $6,185 |
| Trimethoprim Generic | 122 | 308 | 48 | $8,589 |
| Gemtesa Vibegron | 102 | 174 | 25 | $82K |
| Myrbetriq Mirabegron | 102 | 154 | 26 | $69K |
| Solifenacin Succinate Generic | 101 | 160 | 20 | $3,224 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 71 | 71 | 63 | $198 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 66 | 134 | 16 | $813 |
| Orgovyx Relugolix | 48 | 48 | Under 11 | $126K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 47 | 56 | 38 | $715 |
| Potassium Citrate Er Potassium Citrate | 43 | 97 | 16 | $4,278 |
Brand drugs: 470 claims; generic drugs: 2,715 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian J Minnillo $1,892 ($1,892 in general payments such as food, travel and fees) from 17 companies. The largest payer was Boston Scientific Corporation with $482.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 11 | $482 |
| Dendreon Pharmaceuticals LLC | 9 | $296 |
| Calyxo, Inc. | 1 | $264 |
| Ferring Pharmaceuticals Inc. | 9 | $232 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $107 |
| Merck Sharp & Dohme LLC MRK | 3 | $95.29 |
| Teleflex LLC TFX | 2 | $62.72 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $56.99 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $53.89 |
| Astellas Pharma US Inc 4503.T | 3 | $51.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.